Clinical Trial Update: Comparing Treatment Efficacy With Mepolizumab and Omalizumab in Severe Asthma - "Choosebetweenamab". [Phase 4]

View source ↗

Summary

Phase 4 trial comparing efficacy of Mepolizumab versus Omalizumab in severe asthma (Choosebetweenamab). Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)
• Omalizumab (Omalizumab)

Snippet

Sponsor: University of Newcastle, Australia | Conditions: Asthma, Eosinophilic Asthma | Phase 4 | Status: UNKNOWN